Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Forbes

Showing results (241-250 of 309) with videos related to

Pageof 31
Sort By:
The Lancet. Oncology|December 15, 2010
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trialJack Cuzick, Ivana Sestak, Sarah E Pinder, et al.
Molecular Oncology|May 27, 2015
Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancerJay Pundavela, Severine Roselli, Sam Faulkner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
The sequential use of endocrine treatment for advanced breast cancer: where are we?C Barrios, J F Forbes, W Jonat, et al.
The Lancet. Oncology|March 29, 2011
Preventive therapy for breast cancer: a consensus statementJack Cuzick, Andrea DeCensi, Banu Arun, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
BMJ Open|February 26, 2013
Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetesAnne Douglas, Raj S Bhopal, Ruby Bhopal, et al.
Annals of Surgical Oncology|March 25, 2011
Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus ConferenceMasakazu Toi, Eric P Winer, Takashi Inamoto, et al.
Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Endocrine-Related Cancer|July 20, 2007
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction modelRichard J Santen, Norman F Boyd, Rowan T Chlebowski, et al.
Plos One|June 5, 2020
Crisis of confidence averted: Impairment of exercise economy and performance in elite race walkers by ketogenic low carbohydrate, high fat (LCHF) diet is reproducibleLouise M Burke, Avish P Sharma, Ida A Heikura, et al.
Pageof 31

Showing results (241-250 of 309) with videos related to

Sort By:
Pageof 31
The Lancet. Oncology|December 15, 2010
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trialJack Cuzick, Ivana Sestak, Sarah E Pinder, et al.
Molecular Oncology|May 27, 2015
Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancerJay Pundavela, Severine Roselli, Sam Faulkner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
The sequential use of endocrine treatment for advanced breast cancer: where are we?C Barrios, J F Forbes, W Jonat, et al.
The Lancet. Oncology|March 29, 2011
Preventive therapy for breast cancer: a consensus statementJack Cuzick, Andrea DeCensi, Banu Arun, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
BMJ Open|February 26, 2013
Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetesAnne Douglas, Raj S Bhopal, Ruby Bhopal, et al.
Annals of Surgical Oncology|March 25, 2011
Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus ConferenceMasakazu Toi, Eric P Winer, Takashi Inamoto, et al.
Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Endocrine-Related Cancer|July 20, 2007
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction modelRichard J Santen, Norman F Boyd, Rowan T Chlebowski, et al.
Plos One|June 5, 2020
Crisis of confidence averted: Impairment of exercise economy and performance in elite race walkers by ketogenic low carbohydrate, high fat (LCHF) diet is reproducibleLouise M Burke, Avish P Sharma, Ida A Heikura, et al.
Pageof 31